Vaccines are frequently used in veterinary medicine to protect numerous domestic animal species against a long list of pathogens. A noticeable part of commercialized or registered veterinary vaccines use new technologies such as recombinant proteins, deletion of virulence genes, viral vectors, DNA vaccination. These vaccines may also contain a variety of adjuvants. In addition, veterinary research on new vaccine strategies, which allows direct evaluation of protection in target animal species, is very active, including new vectors, nanotechnology, evaluation of TLR (Toll like receptor) ligands or cytokines as adjuvants, per cutaneous route of administration. These information contribute to new knowledge in vaccinology, including for human v...
Breakthroughs in the understanding and manipulation of viral genomes have allowed the emergence ...
Although the veterinary profession remains a major actor in any individual or joint action on animal...
Action 15 of project Ecoantibio 2017 calls among other for an identification of the barriers to vacc...
Les biotechniques récemment développées : recombinaison génétique, synthèse peptidique, fournissent ...
Les vaccins de nouvelles technologies apportent des solutions à certains risques et problèmes des ...
Chez l’homme et les animaux domestiques, les maladies parasitaires dues à des champignons, des proto...
Depuis 100 ans, l’usage de la vaccination a permis de protéger la santé des hommes et des animaux d...
Le développement des vaccins pour l’homme comprend des exigences particulières. Il s’agit, en effet,...
Vaccination is an option among the different tools against animal vector-borne diseases. The animal ...
In daily practice veterinarians are often confronted to a lack of drugs to treat the animal they exa...
Depuis l’interdiction de la vaccination obligatoire contre la Fièvre Aphteuse en France (1991), les ...
Despite their interest to combat mastitis, vaccines are few and underused, owing to limited efficacy...
An epizooty of H5N1 avian flu came out in South East Asia in 2003 and was reported in the beginning ...
L'inoculation d'un vaccin de culture cellulaire du virus bovipestique inactivé par la B-propiolacton...
La demande sur les protéines d’origine animale et en particulier sur les produits avicoles est de pl...
Breakthroughs in the understanding and manipulation of viral genomes have allowed the emergence ...
Although the veterinary profession remains a major actor in any individual or joint action on animal...
Action 15 of project Ecoantibio 2017 calls among other for an identification of the barriers to vacc...
Les biotechniques récemment développées : recombinaison génétique, synthèse peptidique, fournissent ...
Les vaccins de nouvelles technologies apportent des solutions à certains risques et problèmes des ...
Chez l’homme et les animaux domestiques, les maladies parasitaires dues à des champignons, des proto...
Depuis 100 ans, l’usage de la vaccination a permis de protéger la santé des hommes et des animaux d...
Le développement des vaccins pour l’homme comprend des exigences particulières. Il s’agit, en effet,...
Vaccination is an option among the different tools against animal vector-borne diseases. The animal ...
In daily practice veterinarians are often confronted to a lack of drugs to treat the animal they exa...
Depuis l’interdiction de la vaccination obligatoire contre la Fièvre Aphteuse en France (1991), les ...
Despite their interest to combat mastitis, vaccines are few and underused, owing to limited efficacy...
An epizooty of H5N1 avian flu came out in South East Asia in 2003 and was reported in the beginning ...
L'inoculation d'un vaccin de culture cellulaire du virus bovipestique inactivé par la B-propiolacton...
La demande sur les protéines d’origine animale et en particulier sur les produits avicoles est de pl...
Breakthroughs in the understanding and manipulation of viral genomes have allowed the emergence ...
Although the veterinary profession remains a major actor in any individual or joint action on animal...
Action 15 of project Ecoantibio 2017 calls among other for an identification of the barriers to vacc...